Amylyx Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Amylyx Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Amylyx Pharmaceuticals Inc
Rating: 1.48016675
Author: Trendlyne DVM scores

about

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching ...

12.37 0.54 (4.56%)

27.06% Fall from 52W High

297.3K

XNAS Volume

XNAS 09 Jan, 2026 11:39 AM (EST)

Not Eligible

Expensive Valuation

7.2 / 100

Technically Neutral

52.0 / 100

1Yr Price target upside is 63%

9 analysts

Amylyx Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Amylyx Pharma Inc Live Stock Price Today, Share Analysis and Chart

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching ...

27.06% Fall from 52W High

SWOT Analysis

Amylyx Pharma Inc Live Price Chart